News
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...
Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...
A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.
5d
WCMH Columbus on MSNBill would lower price of weight loss prescription drugs for state employeesA new bill could make the price of prescription drugs known for weight loss cheaper for the state of Ohio to buy for its ...
Senior Advocate Diya Kapur, representing the petitioner, informed the court that some gyms were promoting these drugs as a ...
Mounjaro has become popular as a weight loss drug but it also seems to be linked to hair loss in some cases in a worrying new ...
Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...
MHRA launches genetic study into GLP-1 drug risks as Spain investigates Novo Nordisk for potential advertising violations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results